Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends

Author： Katsios Christos   Ziogas Denosthenes E   Roukos Dimitrios H   Baltogiannis George  

Publisher： Informa Healthcare

ISSN： 1747-4124

Source： Expert Review of Gastroenterology and Hepatology, Vol.7, Iss.1, 2013-01, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor Receptor 1 as a Putative Therapy Target in Colorectal Cancer

By  

Digestion, Vol. 88, Iss. 3, 2013-10 ,pp. : 172-181

Karger

Access to resources Recommend Favorite

Colorectal Cancer: Personalized Therapy

By  

Gastrointestinal Tumors, Vol. 1, Iss. 4, 2015-04 ,pp. : 209-220

Karger

Access to resources Recommend Favorite

Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem

By  

Medical Principles and Practice, Vol. 25, Iss. 2, 2016-02 ,pp. : 28-40

Karger

Access to resources Recommend Favorite

New Trends in Vascular Access Therapy

By Kokotis Kathy  

Journal of Vascular Access Devices, Vol. 6, Iss. 2, 2001-0 ,pp. : 7-7

Association of University Programs in Health Administration

Access to resources Recommend Favorite

Growth Hormone Receptor Expression in Human Colorectal Cancer

By Yang Xiaodong   Liu Fukun   Xu Zhe   Chen Che   Li Gang   Wu Xiaoyu   Li Jieshou  

Digestive Diseases and Sciences, Vol. 49, Iss. 9, 2004-09 ,pp. : 1493-1498

Springer Publishing Company

Access to resources Recommend Favorite